[Symposium] Diabetes Mellitus (1)
20 Mar 2026
10:30
12:00
101
Future Management in Diabetes Mellitus
| Time | Session |
|---|---|
|
10:30
11:00
|
Daisuke YabeJapan
Speaker
Advancing toward a Cure for Diabetes: Insights from iPSC-Derived Islet Cell Transplantation TrialIncretin-Based Therapeutics: Bridging Theory and Practice, and Exploring New Horizons
101
|
|
11:00
11:30
|
Kang-Chih FanTaiwan
Speaker
AI-driven precision drug therapy: Tailoring personalized treatment for type 2 diabetesAnti-Obesity Medications: Clinical Use
101
|
|
11:30
12:00
|
Jenny GuntonAustralia
Speaker
Closing the Type 2 Diabetes Gap in Cardiovascular and Renal DiseasePeople with type 2 diabetes die, on average, 6-7 years earlier. This is mostly due to excess cardiovascular events.
This presentation will discuss options for lowering cardiovascular and renal risk in people with type 2 diabetes.Managing Hyperglycaemia in Patients Receiving Immune Checkpoint InhibitorsIt is estimated that >20% of people treated with Immune Checkpoint Inhibitors (ICI) for their cancer will experience new or worsening hyperglycaemia.
This presentation will discuss the differential diagnoses for the cause of hyperglycaemia in people treated with ICI and treatment strategies
101
|